Secondary analysis of the RICCADSA trial: in 126 revascularised CAD patients with nonsleepy OSA and HFpEF-like features, these features improved at 12 months in 38.7% randomised to CPAP vs 20.3% without CPAP (adjusted OR 2.85, 95% CI 1.13–7.22).
Secondary analysisn = 177
Pihtili et al. CPAP therapy may improve HFpEF-like features in coronary artery disease with obstructive sleep apnea: A randomized controlled trial